Details for 2017770546

Up to date per 21.04.2026

Actions

Title / Product Name

NEUARTIGE KRISTALLINE FORM VON 1-(5-(2,4-DIFLUORPHENYL)-1-((3-(FLUORPHENYL)SULFONYL)-4-METHOXY-1H-PYRROL-3-YL)-N-METHYLMETHANAMIN-SALZ

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017770546

EP Publication Number

3433233

E-Number

1293250

Language

PCT Number

KR17002914

Publication Date

30.01.2019 A

22.07.2020 B1

Registration Date

22.07.2020

AT Publication Date

15.08.2020

Application Date

17.03.2017

Registration Number

Priorities

25.03.2016

20160036080

IPC

C07D 207/48 20060101AFI20190708BHEP

Maximum Duration of Protection

17.03.2037

Owner

Daewoong Pharmaceutical Co., Ltd.35-14, Jeyakgongdan 4-gil, Hyangnam-eup Hwaseong-si Gyenoggi-do 18623KR

Representative

Paul CosmoviciGumpendorfer Straße 1421060 WienAT

Inventor

KIM, AeriDAEWOONG PHARMACEUTICAL CO., LTD. 35-14, Jeyakgongdan 4-gil Hyangnam-eup Hwaseong-si Gyeonggi-do 18623KR

CHO, Kwan Hyung111-1902, 156, Hwamyeongsindosi-ro Buk-gu Busan 46525KR

Information about Fees